TY - JOUR
T1 - Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level
AU - O'Donnell, Martin
AU - Hankey, Graeme J.
AU - Rangarajan, Sumathy
AU - Chin, Siu Lim
AU - Rao-Melacini, Purnima
AU - Ferguson, John
AU - Xavier, Denis
AU - Lisheng, Liu
AU - Zhang, Hongye
AU - Pais, Prem
AU - Lopez-Jaramillo, Patricio
AU - Damasceno, Albertino
AU - Langhorne, Peter
AU - Rosengren, Annika
AU - Dans, Antonio L.
AU - Elsayed, Ahmed
AU - Avezum, Alvaro
AU - Mondo, Charles
AU - Smyth, Andrew
AU - Judge, Conor
AU - Diener, Hans Christoph
AU - Ryglewicz, Danuta
AU - Czlonkowska, Anna
AU - Pogosova, Nana
AU - Weimar, Christian
AU - Iqbal, Romana
AU - Diaz, Rafael
AU - Yusoff, Khalid
AU - Yusufali, Afzalhussein
AU - Oguz, Aytekin
AU - Wang, Xingyu
AU - Penaherrera, Ernesto
AU - Lanas, Fernando
AU - Ogah, Okechukwu Samuel
AU - Ogunniyi, Adensola
AU - Iversen, Helle K.
AU - Malaga, German
AU - Rumboldt, Zvonko
AU - Oveisgharan, Shahram
AU - Alhussain, Fawaz
AU - Daliwonga, Magazi
AU - Nilanont, Yongchai
AU - Yusuf, Salim
N1 - Funding Information:
Contributors All authors contributed to the collection of data, discussions and interpretation of the data, and to the writing of the report. All authors reviewed and approved the manuscript for submission. The study was designed, the analyses were planned and the manuscript was drafted by MO’D and SY. Statistical analyses were performed by PR-M and JF. MO’D and SY wrote the first draft of the manuscript. Funding The INTERSTROKE study is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Västra Götaland, and through unrestricted grants from several pharmaceutical companies with major contributions from Astra Zeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MERCK, Sharp and Dohme], Swedish Heart and Lung Foundation, UK Chest, and UK Heart and Stroke. Disclaimer No medical writer or other people were involved in the design, analysis or writing of this manuscript.
Publisher Copyright:
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Objective Hypertension is the most important modifiable risk factor for stroke globally. We hypothesised that country-income level variations in knowledge, detection and treatment of hypertension may contribute to variations in the association of blood pressure with stroke. Methods We undertook a standardised case-control study in 32 countries (INTERSTROKE). Cases were patients with acute first stroke (n=13 462) who were matched by age, sex and site to controls (n=13 483). We evaluated the associations of knowledge, awareness and treatment of hypertension with risk of stroke and its subtypes and whether this varied by gross national income (GNI) of country. We estimated OR and population attributable risk (PAR) associated with treated and untreated hypertension. Results Hypertension was associated with a graded increase in OR by reducing GNI, ranging from OR 1.92 (99% CI 1.48 to 2.49) to OR 3.27 (2.72 to 3.93) for highest to lowest country-level GNI (p-heterogeneity<0.0001). Untreated hypertension was associated with a higher OR for stroke (OR 5.25; 4.53 to 6.10) than treated hypertension (OR 2.60; 2.32 to 2.91) and younger age of first stroke (61.4 vs 65.4 years; p<0.01). Untreated hypertension was associated with a greater risk of intracerebral haemorrhage (OR 6.95; 5.61 to 8.60) than ischaemic stroke (OR 4.76; 3.99 to 5.68). The PAR associated with untreated hypertension was higher in lower-income regions, PAR 36.3%, 26.3%, 19.8% to 10.4% by increasing GNI of countries. Lifetime non-measurement of blood pressure was associated with stroke (OR 1.80; 1.32 to 2.46). Conclusions Deficits in knowledge, detection and treatment of hypertension contribute to higher risk of stroke, younger age of onset and larger proportion of intracerebral haemorrhage in lower-income countries.
AB - Objective Hypertension is the most important modifiable risk factor for stroke globally. We hypothesised that country-income level variations in knowledge, detection and treatment of hypertension may contribute to variations in the association of blood pressure with stroke. Methods We undertook a standardised case-control study in 32 countries (INTERSTROKE). Cases were patients with acute first stroke (n=13 462) who were matched by age, sex and site to controls (n=13 483). We evaluated the associations of knowledge, awareness and treatment of hypertension with risk of stroke and its subtypes and whether this varied by gross national income (GNI) of country. We estimated OR and population attributable risk (PAR) associated with treated and untreated hypertension. Results Hypertension was associated with a graded increase in OR by reducing GNI, ranging from OR 1.92 (99% CI 1.48 to 2.49) to OR 3.27 (2.72 to 3.93) for highest to lowest country-level GNI (p-heterogeneity<0.0001). Untreated hypertension was associated with a higher OR for stroke (OR 5.25; 4.53 to 6.10) than treated hypertension (OR 2.60; 2.32 to 2.91) and younger age of first stroke (61.4 vs 65.4 years; p<0.01). Untreated hypertension was associated with a greater risk of intracerebral haemorrhage (OR 6.95; 5.61 to 8.60) than ischaemic stroke (OR 4.76; 3.99 to 5.68). The PAR associated with untreated hypertension was higher in lower-income regions, PAR 36.3%, 26.3%, 19.8% to 10.4% by increasing GNI of countries. Lifetime non-measurement of blood pressure was associated with stroke (OR 1.80; 1.32 to 2.46). Conclusions Deficits in knowledge, detection and treatment of hypertension contribute to higher risk of stroke, younger age of onset and larger proportion of intracerebral haemorrhage in lower-income countries.
KW - epidemiology
KW - hypertension
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85097961252&partnerID=8YFLogxK
U2 - 10.1136/heartjnl-2019-316515
DO - 10.1136/heartjnl-2019-316515
M3 - Article
C2 - 33318082
AN - SCOPUS:85097961252
SN - 1355-6037
VL - 107
SP - 282
EP - 289
JO - Heart
JF - Heart
IS - 4
ER -